Farmaindustria presents improvements to the Medicines Bill to prepare healthcare for innovation over the next 20 years

Farmaindustria presents improvements to the Draft Medicines Bill to prepare healthcare for innovation in the next 20 yearsThe future law should promote greater investment in healthcare, focusing on biopharmaceutical innovation, R&D and promoting improvements in the availability of new medicines in our country, guaranteeing compliance with the 180-day deadline for the decision on price and […]

Fina Lladós: ‘We have before us a unique opportunity in these legislative developments to transform our healthcare and prepare it for the next 20 years’.

“It is essential to see medicines and healthcare as an economically and socially very profitable investment for Spain. An investment that generates very important benefits in the medium and long term in the health aspect, of course, but also in the social and economic sphere, as it has a positive impact on sectors of great […]

Spain, a European success story in clinical trials of new drugs

eleconomista.es In 2023, Spain overtook Germany as the country that initiated the most clinical trials and became the European leader. This is reflected in the report Evaluating the clinical trial ecosystem in Europe, prepared by the consultancy firm Iqvia for Efpia and Vaccines Europe, which highlights Spain’s role, although it also warns of the continent’s […]

Joint position on the draft Medicines and Medical Devices Law

Joint position on the Draft Bill on Medicines and Health ProductsThe proposed system of price regulation for off-patent medicines puts at risk the supply of medicines and the pharmaceutical industry in Spain. Farmaindustria.es Joint position on the Draft Bill on Medicines and Health Products The Draft Bill on Medicines and Health Products recently approved in […]

The global pharmaceutical industry had 12,700 drugs in development by 2024

The International Federation of Innovative Pharmaceutical Industries indicates that the sector invests almost 30% of its revenues in R&D, amounting to nearly 270 billion euros. Diarofarma.com The pharmaceutical industry leads the world in R&D investment, with 30% of its annual revenues devoted to this item. This amounted to nearly 270 billion euros in 2021, according […]

Regional health officials and Farmaindustria meet to analyse new pharmaceutical regulations, the proper use of medicines and advances in digital health

The Regional Minister of Health of Cantabria, César Pascual, inaugurates the 25th CAAC-Pharmaindustry Forum. ‘When we work together, not only do we promote research and biomedical advances, but we also favour the sustainability of health systems’, stressed the president of Farmaindustria, Fina Lladós. Farmaindustria.es Santander has hosted this Friday the XXV Forum of Autonomous Communities-Pharmaindustry, […]

Spain has more than 1,050 clinical trials for rare diseases underway and nine out of ten are promoted by the pharmaceutical industry.

This research momentum means that one in three new medicines approved by Europe in 2024 was classified as an orphan drug. There are still many untreated rare diseases, so patients are calling for more public investment in research and incentives to grow innovation from the private sector. Farmaindustria joins the ‘people’ campaign, promoted by Feder […]

Distefar has been present at the European Clinical Trial Supply and Temperature controlled logistics in Biopharmaceuticals 2025, on 25th and 26th of February.

Getting to know new markets and establishing contacts with both potential customers and potential suppliers. Temperature control in pharmaceutical logistics is one of our pillars, as well as temperature control in our warehouses. Getting to know employees and customers on a personal level makes for even closer ties, sharing chats, coffees and snacks, which makes […]

The pharmaceutical industry is committed to Spain with investments of 9,000 million euros and asks the Prime Minister to continue supporting legislative reforms that favour innovation, strategic autonomy and predictability.

The President of the Government meets for the second time with around twenty representatives of the national, European and global pharmaceutical industry to intensify public-private collaboration and follow up on the plan launched in 2023. Pedro Sánchez stresses that the pharmaceutical industry is a key asset for our country and a strategic sector on a […]

The pharmaceutical industry generates more than 27 billion euros of added value in Spain, almost 2% of the country’s GDP.

For the first time, a study by the consultancy firm Afi has evaluated the impact of pharmaceutical companies from a dual perspective: the socio-economic value provided by medicines and that generated by the research and manufacture of these products in Spain. According to the report, this sector contributes to three of the main challenges facing […]